Black Diamond Therapeutics Inc (BDTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 0 | 0 | 0 | 0 | 70,000 |
| Gross Profit | N/A | N/A | N/A | N/A | 70,000 |
| Operating Expenses | 11,259 | 17,610 | 10,978 | 13,420 | 15,470 |
| Operating Income | -11,259 | -17,610 | -10,978 | -13,420 | 54,530 |
| Other Income | 2,223 | 2,494 | 2,480 | 2,859 | 2,012 |
| Pre-tax Income | -9,036 | -15,116 | -8,498 | -10,561 | 56,542 |
| Net Income Continuous | -9,036 | -15,116 | -8,498 | -10,561 | 56,542 |
| Net Income | $-9,036 | $-15,116 | $-8,498 | $-10,561 | $56,542 |
| EPS Basic Total Ops | -0.16 | -0.27 | -0.15 | -0.19 | 1.00 |
| EPS Basic Continuous Ops | -0.16 | -0.27 | -0.15 | -0.19 | 1.00 |
| EPS Diluted Total Ops | -0.16 | -0.25 | -0.15 | -0.19 | 0.98 |
| EPS Diluted Continuous Ops | -0.16 | -0.26 | -0.15 | -0.19 | 0.98 |
| EPS Diluted Before Non-Recurring Items | -0.16 | -0.14 | -0.15 | -0.19 | 0.98 |
| EBITDA(a) | $-11,232 | $-17,544 | $-10,892 | $-13,334 | $54,617 |